Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate

Cat. No.: HY-76558 Pureza: 99.28%: Ficha de datos
COA

SDS
Instrucciones de manejo
FAQs
Technical Support

Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate is a drug intermediate. Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate can be used to synthesize inhibitors of various kinases such as Cdk4, PDGF, FGF, EGF.

Para uso exclusivo en investigación. No vendemos a pacientes.

Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate Estructura química

No. CAS : 5909-24-0

Tamaño	Stock	Cantidad
25 g	En stock	Estimated Time of Arrival: December 31
100 g	En stock	Estimated Time of Arrival: December 31
> 100 g	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 1 Customer Validation

Recomendaciones destacadas

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate is a drug intermediate. Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate can be used to synthesize inhibitors of various kinases such as Cdk4, PDGF, FGF, EGF^[1]^[2].
Peso molecular	232.69
Fòrmula	C₈H₉ClN₂O₂S
No. CAS	5909-24-0
Appearance	Solid
Color	White to off-white
SMILES	O=C(OCC)C1=CN=C(SC)N=C1Cl
Envío	Room temperature in continental US; may vary elsewhere.
Almacenamiento	-20°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Pureza y Documentación	Purity: 99.85% Select Batch: Ficha de datos (267 KB) SDS (394 KB) COA (247 KB) HNMR (116 KB) RP-HPLC (241 KB) Instrucciones de manejo (2659 KB)
Referencias	[1]. Barvian M, et al. Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases. J Med Chem. 2000 Nov 30;43(24):4606-16. [Content Brief] [2]. Klutchko SR, et al. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity. J Med Chem. 1998 Aug 13;41(17):3276-92. [Content Brief]